Lates News

Every Economy AI Express, Pacific Securities issued a research report on April 30th, giving Bio-Kangt biomaterial Co., Ltd. (688526.SH) a buy rating. The main reasons for the rating include: 1) Industry competition intensification in 2024 leads to pressure on product gross margins; 2) In 2025, new major products are expected to achieve sales breakthroughs. (Daily Economic News)